A Phase II, Single Center, Proof-of-concept Study of Birinapant in Combination With Platinum Based Chemotherapy in Participants With Advanced Newly Diagnosed or Recurrent High Grade Serous Carcinomas

Trial Profile

A Phase II, Single Center, Proof-of-concept Study of Birinapant in Combination With Platinum Based Chemotherapy in Participants With Advanced Newly Diagnosed or Recurrent High Grade Serous Carcinomas

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 31 Jan 2017

At a glance

  • Drugs Birinapant (Primary) ; Carboplatin; Paclitaxel
  • Indications Endometrial cancer; Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 27 Oct 2016 Planned initiation date changed from 1 Jul 2016 to 1 Jan 2017.
    • 04 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top